Next 10 |
home / stock / luv:cc / luv:cc news
VANCOUVER, BC, CANADA, May 25, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (formerly Love Pharma Inc.) (“Jolt” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) is pleased to announce that pursuant to a 10% interest bearing convertible debenture issued on October 12, 2022...
Toronto, Ontario--(Newsfile Corp. - Le 25 mai/May 2023) - Love Pharma Inc. (LUV) has announced a name and symbol change to Jolt Health Inc. (JOLT). Shares will begin trading under the new name and symbol and with a new CUSIP number on May 26, 2023. Disclosure documents are available at ww...
VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has changed its name to “Jolt Health Inc.”. The board of directors of the Company approve...
VANCOUVER, BC, CANADA, April 05, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is currently evaluating mining opportunities in the battery component and power metals space. The move comes as the company aims to build ...
VANCOUVER, BC, CANADA, April 03, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has issued a total of 5,035,000 options pursuant to its incentive stock option plan (“Plan”) ...
Toronto, Ontario--(Newsfile Corp. - le 28 février/February 2023) - Love Pharma Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares. As a result, the outstand...
VANCOUVER, BC / ACCESSWIRE / February 27, 2023 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0) announced it intends to proceed with a consolidation of its common shares (each, a "Share") on the basis of ten (10) pre-consolidation Shares for one (1) post-consolidation Share (...
VANCOUVER, BC / ACCESSWIRE / December 14, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0) , the Company today announced a strategic move to sell its wholly owned subsidiary Microdoz Therapy Inc. ("Microdoz"), as part of its ongoing efforts to optimize its portfolio and fo...
VANCOUVER, British Columbia, Nov. 07, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0) continues with its plans to develop a portfolio of innovative products encompassing transdermal drug delivery applications. On October 11th, LOVE Pharma signed a nonbinding Letter of Intent to ac...
NEW YORK, NY, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0), an international mental health and sexual wellness company, has been explicit about its plans to develop a portfolio of innovative products encompassing transdermal drug delivery applications in the add...
News, Short Squeeze, Breakout and More Instantly...
Love Pharma Inc. Company Name:
LUV:CC Stock Symbol:
CNQC Market:
VANCOUVER, BC, CANADA, May 25, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (formerly Love Pharma Inc.) (“Jolt” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) is pleased to announce that pursuant to a 10% interest bearing convertible debenture issued on October 12, 2022...
Toronto, Ontario--(Newsfile Corp. - Le 25 mai/May 2023) - Love Pharma Inc. (LUV) has announced a name and symbol change to Jolt Health Inc. (JOLT). Shares will begin trading under the new name and symbol and with a new CUSIP number on May 26, 2023. Disclosure documents are available at ww...
VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has changed its name to “Jolt Health Inc.”. The board of directors of the Company approve...